VENUS Study | Article

Katsuta T*, Sato S, Kawazoe Y, Fukuda H.

Active vaccine safety monitoring system using health insurance claims data in Japan: The Vaccine Effectiveness, Networking, and Universal Safety (VENUS) study.

Vaccine 2026; in press.

Kawazoe Y*, Katsuta T, Tanaka T, Nakamura Y, Sato S, Maeda M, Oda F, Fukuda H.

Prevalence of HPV Vaccine–Associated Symptoms in Unvaccinated Japanese Adolescents: A Descriptive Study from the VENUS Study Database.

Vaccine 2026; 70: 128020.

Sazawa M, Ishiguro C, Mimura W, Maeda M, Murata F, Fukuda H.

Impact of the resumption of proactive recommendation of HPV vaccination on HPV vaccination rates in Japan: An interrupted time series analysis based on the VENUS Study.

BMJ Public Health 2025; 3: e000982.

Ishiguro C*, Mimura W, Oda F, Maeda M, Fukuda H.

Population-Based Cohort Study Assessing the Effectiveness of Maternal BNT162b2/mRNA-1273 Vaccination Against Infant Coronavirus Disease 2019 Outcomes During Omicron Predominance: The VENUS Study .

Human Vaccines & Immunotherapeutics 2025; 21(1): 2585595.

Maeda M, Murata F, Fukuda H.

Effects of the introduction of a routine rotavirus vaccination program on vaccination coverage and factors in a Japanese municipality: The VENUS Study.

BMJ Public Health2025; 3: e002149.

Murata F, Maeda M, Fukuda H*.

Claims-based analysis of zoster vaccine effectiveness against incident herpes zoster: The VENUS Study.

JMA Journal 2025; 8(4): 1399-1402.

Sato S, Kawazoe Y, Murata F, Maeda M, Fukuda H.

Estimation of the adjusted risk difference for very rare events, large samples, and extreme exposure frequency: Application of Vaccine Effectiveness, Networking, and Universal Safety study.